A 45-reference UltraGene range, new respiratory panels and high-multiplex prototypes strengthen ABL Diagnostics ...
DeepChek® NGS ecosystem maps viral resistance mutations to next-generation therapies, unlocking new insights for ...
ABL Diagnostics (Paris:ABLD) (Euronext Paris – Compartment B – ISIN: FR001400AHX6), a company specialized in molecular diagnostic solutions, healthcare software, and clinical sample management, today ...
Small-satellite launch company ABL Space Systems is gearing up for its first-ever liftoff. ABL completed a key fueling test, called a wet dress rehearsal, with its RS1 rocket on the pad at the Pacific ...
The blood-brain barrier (BBB) serves as a protective barrier that restricts the entry of harmful substances and agents into the brain and is considered a significant obstacle in the development of ...
ABL Bio starts US phase 1 dosing for two bispecific ADCs Neok Bio begins U.S. phase 1 trials of dual-target ADCs ABL206 and ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Rocket builder ABL Space closed a $170 million round of funding with a $1.3 billion valuation, making it the latest private space venture to reach unicorn status. ABL raised the funds from T. Rowe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results